Jiayi Shen

Jiayi Shen

Auto-generated profile, based on publicly available information

Jiayi Shen

Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2019 in JMIR Medical Informatics
Verified
Journal Article
Open access
JSJiayi Shen
Jiayi Shen
Casper J.P. ZhangCasper J.P. Zhang
Casper J.P. Zhang
BJBangsheng Jiang
Bangsheng Jiang
JCJiebin Chen
Jiebin Chen
JSJian Song
Jian Song
WMWai-Kit Ming
Wai-Kit Ming
Background: Artificial intelligence (AI) has been extensively used in a range of medical fields to promote therapeutic development. The development of diverse AI techniques has also contributed to early detections, disease diagnoses, and referral management. However, concerns about the value of advanced AI in disease diagnosis have been raised by health care professionals, medical service providers, and health policy decision makers. Objective: This review aimed to systematically examine the literature, in particular, focusing on the performance comparison between advanced AI and human clinicians to provide an up-to-date summary regarding the extent of the application of AI to disease diagnoses. By doing so, this review discussed the relationship between the current advanced AI development and clinicians with respect to disease diagnosis and thus therapeutic development in the long run. Methods: We systematically searched articles published between January 2000 and March 2019 following the Preferred Reporting Items for Systematic reviews and Meta-Analysis in the following databases: Scopus, PubMed, CINAHL, Web of Science, and the Cochrane Library. According to the preset inclusion and exclusion criteria, only articles comparing the medical performance between advanced AI and human experts were considered. Results: A total of 9 articles were identified. A convolutional neural network was the commonly applied advanced AI technology. Owing to the variation in medical fields, there is a distinction between individual studies in terms of classification, labeling, training process, dataset size, and algorithm validation of AI. Performance indices reported in articles included diagnostic accuracy, weighted errors, false-positive rate, sensitivity, specificity, and the area under the receiver operating characteristic curve. The results showed that the performance of AI was at par with that of clinicians and exceeded that of clinicians with less experience. Conclusions: Current AI development has a diagnostic performance that is comparable with medical experts, especially in image recognition-related fields. Further studies can be extended to other types of medical imaging such as magnetic resonance imaging and other medical practices unrelated to images. With the continued development of AI-assisted technologies, the clinical implications underpinned by clinicians’ experience and guided by patient-centered health care principle should be constantly considered in future AI-related and other technology-based medical research.

6 June 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JLJiawei Lv
Jiawei Lv
YWYuan Wei
Yuan Wei
JYJian-Hua Yin
Jian-Hua Yin
YCYu-Pei Chen
Yu-Pei Chen
GZGuan-Qun Zhou
Guan-Qun Zhou
JMJun Ma
Jun Ma

18 March 2020 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
YCYu-Tong Chen
Yu-Tong Chen
JSJia-Yi Shen
Jia-Yi Shen
DCDong-Ping Chen
Dong-Ping Chen
CWChen-Fei Wu
Chen-Fei Wu
RGRui Guo
Rui Guo
YCYu-Pei Chen
Yu-Pei Chen
Methylation of RNA and DNA, notably in the forms of N6-methyladenosine (m6A) and 5-methylcytosine (5mC) respectively, plays crucial roles in diverse biological processes. Currently, there is a lack of knowledge regarding the cross-talk between m6A and 5mC regulators. Thus, we systematically performed a pan-cancer genomic analysis by depicting the molecular correlations between m6A and 5mC regulators across ~ 11,000 subjects representing 33 cancer types. For the first time, we identified cross-talk between m6A and 5mC methylation at the multiomic level. Then, we further established m6A/5mC epigenetic module eigengenes by combining hub m6A/5mC regulators and informed a comprehensive epigenetic state. The model reflected status of the tumor-immune-stromal microenvironment and was able to predict patient survival in the majority of cancer types. Our results lay a solid foundation for epigenetic regulation in human cancer and pave a new road for related therapeutic targets.

15 September 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JSJiayi Shen
Jiayi Shen
JCJiebin Chen
Jiebin Chen
ZZZequan Zheng
Zequan Zheng
JZJiabin Zheng
Jiabin Zheng
ZLZherui Liu
Zherui Liu
WMWai-Kit Ming
Wai-Kit Ming
Background: Gestational diabetes mellitus (GDM) can cause adverse consequences to both mothers and their newborns. However, pregnant women living in low- and middle-income areas or countries often fail to receive early clinical interventions at local medical facilities due to restricted availability of GDM diagnosis. The outstanding performance of artificial intelligence (AI) in disease diagnosis in previous studies demonstrates its promising applications in GDM diagnosis. Objective: This study aims to investigate the implementation of a well-performing AI algorithm in GDM diagnosis in a setting, which requires fewer medical equipment and staff and to establish an app based on the AI algorithm. This study also explores possible progress if our app is widely used. Methods: An AI model that included 9 algorithms was trained on 12,304 pregnant outpatients with their consent who received a test for GDM in the obstetrics and gynecology department of the First Affiliated Hospital of Jinan University, a local hospital in South China, between November 2010 and October 2017. GDM was diagnosed according to American Diabetes Association (ADA) 2011 diagnostic criteria. Age and fasting blood glucose were chosen as critical parameters. For validation, we performed k-fold cross-validation (k=5) for the internal dataset and an external validation dataset that included 1655 cases from the Prince of Wales Hospital, the affiliated teaching hospital of the Chinese University of Hong Kong, a non-local hospital. Accuracy, sensitivity, and other criteria were calculated for each algorithm. Results: The areas under the receiver operating characteristic curve (AUROC) of external validation dataset for support vector machine (SVM), random forest, AdaBoost, k-nearest neighbors (kNN), naive Bayes (NB), decision tree, logistic regression (LR), eXtreme gradient boosting (XGBoost), and gradient boosting decision tree (GBDT) were 0.780, 0.657, 0.736, 0.669, 0.774, 0.614, 0.769, 0.742, and 0.757, respectively. SVM also retained high performance in other criteria. The specificity for SVM retained 100% in the external validation set with an accuracy of 88.7%. Conclusions: Our prospective and multicenter study is the first clinical study that supports the GDM diagnosis for pregnant women in resource-limited areas, using only fasting blood glucose value, patients’ age, and a smartphone connected to the internet. Our study proved that SVM can achieve accurate diagnosis with less operation cost and higher efficacy. Our study (referred to as GDM-AI study, ie, the study of AI-based diagnosis of GDM) also shows our app has a promising future in improving the quality of maternal health for pregnant women, precision medicine, and long-distance medical care. We recommend future work should expand the dataset scope and replicate the process to validate the performance of the AI algorithms.

6 January 2023 in Science Advances
Verified
Journal Article
Closed access
YWYa-Qin Wang
Ya-Qin Wang
DWDong-Hong Wu
Dong-Hong Wu
DWDenghui Wei
Denghui Wei
JSJia-Yi Shen
Jia-Yi Shen
ZHZi-Wei Huang
Zi-Wei Huang
YCYu-Pei Chen
Yu-Pei Chen
The molecular basis underlying nasopharyngeal carcinoma (NPC) remains unclear. Recent progress in transcriptional regulatory network analysis helps identify the master regulator (MR) proteins that transcriptionally define malignant tumor phenotypes. Here, we investigated transcription factor-target interactions and identified TEA domain transcription factor 4 (TEAD4) as an MR of high-risk NPC. Precisely, TEAD4 promoted NPC migration, invasion and cisplatin resistance, depending on its autopalmitoylation. Mechanistically, YTHDF2 (YTH domain family 2) recognized WTAP (Wilms tumor 1–associating protein)–mediated TEAD4 m 6 A methylation to facilitate its stability and led to aberrant up-regulation of TEAD4. Up-regulated TEAD4 further drove NPC progression by transcriptionally activating BZW2 (basic leucine zipper and W2 domains 2) to induce the oncogenic AKT pathway. Moreover, the transcriptional activity of TEAD4 was independent of its canonical coactivators YAP/TAZ. Clinically, TEAD4 serves as an independent predictor of unfavorable prognosis and cisplatin response in NPC. Our data revealed the crucial role of TEAD4 in driving tumor malignancy, thus, may provide therapeutic vulnerability in NPC.

29 January 2019 in JMIR Medical Informatics
Verified
Journal Article
Open access
QLQian Liu
Qian Liu
QCQiuyi Chen
Qiuyi Chen
JSJiayi Shen
Jiayi Shen
HWHuailiang Wu
Huailiang Wu
YSYimeng Sun
Yimeng Sun
WMWai-Kit Ming
Wai-Kit Ming
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Third-hand smoke (THS) has been a growing topic for decades in China. Third-hand smoke consists of residual tobacco smoke pollutants that remain on surfaces and in dust and these pollutants are re-emitted into the gas phase or react with oxidants and other compounds in the environment to yield secondary pollutants. Objective: Collecting media reports from major media outlets and analyzing this subject using topic modeling can facilitate a better understanding of the role that the media plays in communicating this health concept. Methods: The data were retrieved from the Huike and Factiva news databases. A preliminary investigation of the Factiva database, focusing on articles dated between January 1, 2013 and December 31, 2017 and Latent Dirichlet Allocation (LDA) yielded the top 10 topics about the THS. The use of the modified tool LDAvis enables an overall view of the topic model that visualizes different topics as circles; multidimensional scaling is used to represent the inter-topic distances on a two-dimensional plane. Results: Seven hundred and forty-five articles were found dated between January 1, 2013 and December 31, 2017. The United States ranked 1st in terms of publications (152 articles on THS from 2013 -2017). We found 279 news reports about THS from the Chinese media over the same period and 363 news reports from the United States. Given our analysis of the percentage of news related to THS in China, topic 1, “cancer,” was the most popular among the topics. This topic was noted in 31.9% of all news stories. Topic 2, “control of quitting smoking,” was related to roughly 15% news on THS. Conclusions: Our study showed that (1) related diseases, (2) air and particulate matter (PM2.5), and (3) control and restrictions are the major concerns of the Chinese media reporting on THS.